In contrast CD44+ stem-like cells, isolated from colorectal cancer cell line, displayed reduced topo I activity and insensitivity of the enzyme to camptothecin, compared to the CD44− subpopulation [38]. This evidence concerns the gene CD44 and colorectal cancer.